Upcoming Issue Highlights
Home Subscribe Advertise Sourcebook Free Product Info Home

Kappa Bioscience Announces the Formation of Scientific Advisory Board

Albion Minerals®

Kappa Bioscience (Oslo, Norway) has announced the formation of a “Blue Ribbon” scientific and medical advisory board to Kappa Biosciencesupport and expand the scientific knowledge base for vitamin K2.

The board reflects Kappa’s unique commitment to growing awareness of the rapidly expanding range of benefits associated with vitamin K2 in the form of Menaquinone 7 (MK-7). It will include world authorities in relevant fields of science, including cardiology, immunology, kinesiology and molecular nutrition, and will set a new standard for the scientific support and advancement of emerging nutritional compounds.

The current composition of the advisory board includes:

  • John Ivy, the Teresa Lozano Long Endowed Chair Emeritus at the University of Texas at Austin.
  • Susanne Talcott, associate professor Texas A&M University, Food Science & Technology​, molecular researcher.
  • Nathan Wong, cardiovascular epidemiologist, a specialist in preventive cardiology, and professor and director, Heart Disease Prevention Program, Division of Cardiology at the University of California.

Kappa Bioscience will announce additional members in the immediate future.

“The formation of Kappa’s scientific and medical advisory board is a further demonstration of the company’s commitment to maintaining its leadership position in the K2 sector and to bringing its remarkable health benefits to a growing number of consumers worldwide,” stated Egil Greve, Kappa’s CEO.  “We are honored to have attracted this esteemed group of scientists. The top-class experts together have authored more than 700 scientific papers. We are confident that with their help, awareness of vitamin K2 and its scope of benefits will rapidly accelerate.”

Trygve Bergeland, PhD, vice president science, will lead the group and coordinate their activities with Kappa’s current research initiatives already underway, according to the company. “The addition of this unique group of scientists to our highly qualified internal science team dramatically expands the scope of scientific support possible for Kappa’s platform ingredient,” said Bergeland. “Together, we believe that we will be able to establish a recommended daily intake for K2 for all people as an essential nutrient, as well as raising awareness of its role in maintaining health.”

For more information, visit www.kappabio.com.